The FDA today approved the first non-opioid treatment designed to help manage the symptoms of opioid withdrawal in adults.
The drug, Lucemyra, isn’t a treatment for opioid use disorder, the agency noted. Instead, it is meant to be used as part of a broader plan to help adults manage their symptoms when they stop using opioids.
Get the full story at our sister site, Drug Delivery Business News.